Sort
23,748 grants matching “melanoma”
Project 1: Isolation Chemistry of Plants and U.S. Lichens and Biological Evaluation
$393,454Alan Douglas Kinghorn · Ohio State University · P01 · FY2025 · CA
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation
$393,450Eric Kirk Lau · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Leveraging cancer-evolved resistance mechanisms to enhance EZH2 activity in adoptive T cells
$393,401Alan Jackson Tackett · Univ Of Arkansas For Med Scis · R21 · FY2024 · CA
The Inhibition of HNSCC Growth and Metastasis by Targeting KDM4A
$393,397Cun-Yu Wang · University Of California Los Angeles · R01 · FY2022 · DE
Mechanisms of Lymphatic Metastasis in Melanoma
$393,323Mihaela Skobe · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Engineering Nanomaterials to Prime Immunity
$393,246James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome
$393,195Hans Ragnar Widlund · Brigham And Women'S Hospital · R01 · FY2018 · CA
Mechanism-based strategies to target oncogenic BRAF signaling
$393,164Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Selective Targeting Survivin for Cancer Therapy
$393,127Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2016 · CA
Development of anti-angiogenesis therapy targeting integrin
$393,091Zhi-Ren Liu · Georgia State University · R01 · FY2017 · CA
Nanoscience of Self 2.0: blocking CD47 recognition by phagocytes in blood & solid tumor clearance
$393,055Dennis E. Discher · University Of Pennsylvania · R01 · FY2022 · HL
Nanoscience of Self 2.0: blocking CD47 recognition by phagocytes in blood & solid tumor clearance
$393,055Dennis E. Discher · University Of Pennsylvania · R01 · FY2020 · HL
Nanoscience of Self 2.0: blocking CD47 recognition by phagocytes in blood & solid tumor clearance
$393,055Dennis E. Discher · University Of Pennsylvania · R01 · FY2021 · HL
Nanoscience of Self 2.0: blocking CD47 recognition by phagocytes in blood & solid tumor clearance
$393,055Dennis E. Discher · University Of Pennsylvania · R01 · FY2019 · HL
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$393,001Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Tumor Immune MicroEnvironment Facility (Scientific Core)
$392,937Wiem Lassoued · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors
$392,929Ann Richmond · Vanderbilt University · R01 · FY2020 · CA
Adoptive T cell Therapy of Melanoma Targeting NY-ESO-1
$392,915Cassian Yee · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
$392,894Wei Dai · New York University School Of Medicine · R01 · FY2013 · ES
In situ radioimmunotherapy to maximize the engagement of conventional type 1 dendritic cells against non-T cell-inflamed tumors
$392,779Fumito Ito · University Of Southern California · R01 · FY2025 · CA
Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma
$392,721Devanand Sarkar · Virginia Commonwealth University · R01 · FY2024 · CA
Dendritic Cell Vaccines to Elicit Polyspecific ThI type Anti- Tumor Immunity
$392,647Louis D Falo · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$392,596Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Molecular Interactions During Neural Crest Formation
$392,531Martin Ignacio Garcia-Castro · Yale University · R01 · FY2011 · DE
Project 1: Murine Modeling of Tumor-Mediated Immunosuppression
$392,528Edgar G. Engleman · Stanford University · U54 · FY2016 · CA